Candesartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. It is available as a prodrug in the form of candesartan cilexetil.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Alfuzosin | Alfuzosin may increase the hypotensive activities of Candesartan. |
| Aliskiren | The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Candesartan. |
| Amifostine | Candesartan may increase the hypotensive activities of Amifostine. |
| Canagliflozin | The risk or severity of hypotension, hyperkalemia, and reduced intravascular volume can be increased when Canagliflozin is combined with Candesartan. |
| Diazoxide | Diazoxide may increase the hypotensive activities of Candesartan. |
| Drospirenone | The risk or severity of hyperkalemia can be increased when Candesartan is combined with Drospirenone. |
| Eplerenone | The risk or severity of hyperkalemia can be increased when Eplerenone is combined with Candesartan. |
| Semuloparin | The risk or severity of hyperkalemia can be increased when Semuloparin is combined with Candesartan. |
| Lithium citrate | The serum concentration of Lithium citrate can be increased when it is combined with Candesartan. |
| Lithium carbonate | The serum concentration of Lithium carbonate can be increased when it is combined with Candesartan. |
| Lithium hydroxide | The serum concentration of Lithium hydroxide can be increased when it is combined with Candesartan. |
| Methylphenidate | Methylphenidate may decrease the antihypertensive activities of Candesartan. |
| Dexmethylphenidate | Dexmethylphenidate may decrease the antihypertensive activities of Candesartan. |
| Obinutuzumab | Candesartan may increase the hypotensive activities of Obinutuzumab. |
| Pentoxifylline | Pentoxifylline may increase the hypotensive activities of Candesartan. |
| Rituximab | Candesartan may increase the hypotensive activities of Rituximab. |
| Tolvaptan | The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Candesartan. |
| Trimethoprim | The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Candesartan. |
| Desmopressin | Desmopressin may decrease the antihypertensive activities of Candesartan. |
| Phentermine | Phentermine may decrease the antihypertensive activities of Candesartan. |
| Midodrine | Midodrine may decrease the antihypertensive activities of Candesartan. |
| Isoetharine | Isoetharine may decrease the antihypertensive activities of Candesartan. |
| Methysergide | Methysergide may decrease the antihypertensive activities of Candesartan. |
| Atomoxetine | Atomoxetine may decrease the antihypertensive activities of Candesartan. |
| Etomidate | Etomidate may decrease the antihypertensive activities of Candesartan. |
| Zolmitriptan | Zolmitriptan may decrease the antihypertensive activities of Candesartan. |
| Dihydroergotamine | Dihydroergotamine may decrease the antihypertensive activities of Candesartan. |
| Protriptyline | Protriptyline may decrease the antihypertensive activities of Candesartan. |
| Methylergometrine | Methylergometrine may decrease the antihypertensive activities of Candesartan. |
| Norepinephrine | Norepinephrine may decrease the antihypertensive activities of Candesartan. |
| Mirtazapine | Mirtazapine may decrease the antihypertensive activities of Candesartan. |
| Phenylephrine | Phenylephrine may decrease the antihypertensive activities of Candesartan. |
| Phenylpropanolamine | Phenylpropanolamine may decrease the antihypertensive activities of Candesartan. |
| Droperidol | Droperidol may decrease the antihypertensive activities of Candesartan. |
| Buspirone | Buspirone may decrease the antihypertensive activities of Candesartan. |
| Nortriptyline | Nortriptyline may decrease the antihypertensive activities of Candesartan. |
| Amoxapine | Amoxapine may decrease the antihypertensive activities of Candesartan. |
| Doxapram | Doxapram may decrease the antihypertensive activities of Candesartan. |
| Atropine | Atropine may decrease the antihypertensive activities of Candesartan. |
| Lisuride | Lisuride may decrease the antihypertensive activities of Candesartan. |
| Metaraminol | Metaraminol may decrease the antihypertensive activities of Candesartan. |
| Trazodone | Trazodone may decrease the antihypertensive activities of Candesartan. |
| Ergotamine | Ergotamine may decrease the antihypertensive activities of Candesartan. |
| Nicergoline | Nicergoline may decrease the antihypertensive activities of Candesartan. |
| Methoxamine | Methoxamine may decrease the antihypertensive activities of Candesartan. |
| Propiomazine | Propiomazine may decrease the antihypertensive activities of Candesartan. |
| Alfentanil | Alfentanil may decrease the antihypertensive activities of Candesartan. |
| Fentanyl | Fentanyl may decrease the antihypertensive activities of Candesartan. |
| Orciprenaline | Orciprenaline may decrease the antihypertensive activities of Candesartan. |
| Phenmetrazine | Phenmetrazine may decrease the antihypertensive activities of Candesartan. |
| Dobutamine | Dobutamine may decrease the antihypertensive activities of Candesartan. |
| Pseudoephedrine | Pseudoephedrine may decrease the antihypertensive activities of Candesartan. |
| Benzphetamine | Benzphetamine may decrease the antihypertensive activities of Candesartan. |
| Ritodrine | Ritodrine may decrease the antihypertensive activities of Candesartan. |
| Terbutaline | Terbutaline may decrease the antihypertensive activities of Candesartan. |
| Bitolterol | Bitolterol may decrease the antihypertensive activities of Candesartan. |
| Diethylpropion | Diethylpropion may decrease the antihypertensive activities of Candesartan. |
| Salmeterol | Salmeterol may decrease the antihypertensive activities of Candesartan. |
| Naratriptan | Naratriptan may decrease the antihypertensive activities of Candesartan. |
| Rizatriptan | Rizatriptan may decrease the antihypertensive activities of Candesartan. |
| Dopamine | Dopamine may decrease the antihypertensive activities of Candesartan. |
| Frovatriptan | Frovatriptan may decrease the antihypertensive activities of Candesartan. |
| Albuterol | Salbutamol may decrease the antihypertensive activities of Candesartan. |
| Ergoloid mesylate | Ergoloid mesylate may decrease the antihypertensive activities of Candesartan. |
| Isoprenaline | Isoprenaline may decrease the antihypertensive activities of Candesartan. |
| Arbutamine | Arbutamine may decrease the antihypertensive activities of Candesartan. |
| Dutasteride | Dutasteride may decrease the antihypertensive activities of Candesartan. |
| Nefazodone | Nefazodone may decrease the antihypertensive activities of Candesartan. |
| Desipramine | Desipramine may decrease the antihypertensive activities of Candesartan. |
| Pergolide | Pergolide may decrease the antihypertensive activities of Candesartan. |
| Finasteride | Finasteride may decrease the antihypertensive activities of Candesartan. |
| Ergometrine | Ergometrine may decrease the antihypertensive activities of Candesartan. |
| Lisdexamfetamine | Lisdexamfetamine may decrease the antihypertensive activities of Candesartan. |
| Fenoterol | Fenoterol may decrease the antihypertensive activities of Candesartan. |
| Pirbuterol | Pirbuterol may decrease the antihypertensive activities of Candesartan. |
| Ephedra sinica root | Ephedra sinica root may decrease the antihypertensive activities of Candesartan. |
| Ephedrine | Ephedrine may decrease the antihypertensive activities of Candesartan. |
| Mephentermine | Mephentermine may decrease the antihypertensive activities of Candesartan. |
| Procaterol | Procaterol may decrease the antihypertensive activities of Candesartan. |
| Yohimbine | Yohimbine may decrease the antihypertensive activities of Candesartan. |
| Methotrimeprazine | Methotrimeprazine may decrease the antihypertensive activities of Candesartan. |
| Clenbuterol | Clenbuterol may decrease the antihypertensive activities of Candesartan. |
| Bambuterol | Bambuterol may decrease the antihypertensive activities of Candesartan. |
| MMDA | MMDA may decrease the antihypertensive activities of Candesartan. |
| Midomafetamine | Midomafetamine may decrease the antihypertensive activities of Candesartan. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may decrease the antihypertensive activities of Candesartan. |
| 4-Methoxyamphetamine | 4-Methoxyamphetamine may decrease the antihypertensive activities of Candesartan. |
| 4-Bromo-2,5-dimethoxyamphetamine | 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Candesartan. |
| Tenamfetamine | Tenamfetamine may decrease the antihypertensive activities of Candesartan. |
| Chlorphentermine | Chlorphentermine may decrease the antihypertensive activities of Candesartan. |
| Dextroamphetamine | Dextroamphetamine may decrease the antihypertensive activities of Candesartan. |
| Metamfetamine | Metamfetamine may decrease the antihypertensive activities of Candesartan. |
| Phendimetrazine | Phendimetrazine may decrease the antihypertensive activities of Candesartan. |
| Solifenacin | Solifenacin may decrease the antihypertensive activities of Candesartan. |
| Periciazine | Periciazine may decrease the antihypertensive activities of Candesartan. |
| Acepromazine | Acepromazine may decrease the antihypertensive activities of Candesartan. |
| Thioproperazine | Thioproperazine may decrease the antihypertensive activities of Candesartan. |
| Zuclopenthixol | Zuclopenthixol may decrease the antihypertensive activities of Candesartan. |
| 1-benzylimidazole | 1-benzylimidazole may decrease the antihypertensive activities of Candesartan. |
| Lysergic acid diethylamide | Lysergic acid diethylamide may decrease the antihypertensive activities of Candesartan. |